Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Infective Endocarditis
2005 Standout
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
2011
The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease
2004
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
2008
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
2009
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
2002
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction
1999
Diabetic retinopathy
2010 Standout
Liver fibrosis
2005 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Diabetic renal disease: from recent studies to improved clinical practice
2004
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
2008
Hypertension and diabetes
2002
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
The metabolic syndrome
2010 Standout
Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases
2011
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
2010
Diuretic and Enhanced Sodium Restriction Results in Improved Antiproteinuric Response to RAS Blocking Agents
2004
Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes
2006
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
2010
Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes*
2003
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
2002
Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review
2011
Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
2011
Chronic kidney disease
2011 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Diabetic Retinopathy
2012 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The metabolic syndrome
2005 Standout
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney
2003
How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?
2003
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
2001
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
1990 StandoutNobel
Nephropathy in Patients with Type 2 Diabetes
2002
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Sex, haemoglobin and kidney disease: new perspectives
2005
Type 1 diabetes
2013 Standout
Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy
2005
Combination Therapy With an Angiotensin Receptor Blocker and an ACE Inhibitor in Proteinuric Renal Disease: A Systematic Review of the Efficacy and Safety Data
2006
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy
2003
Natural history of mitral valve prolapse
1995
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
2009
The RAAS in the pathogenesis and treatment of diabetic nephropathy
2010
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy
2004
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study
2011
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
2003
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study*
2005
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Left ventricular hypertrophy, cardiac diseases and hypertension: Recent experiences
1989
Infective endocarditis
2004 Standout
Attenuated Antibody Reaction for the Primary Antigen but not for the Recall Antigen of Influenza Vaccination in Patients with Non-Hodgkin B-Cell Lymphoma after the Administration of Rituximab-CHOP
2009
Determination of Left Ventricular Mass by Echocardiography in a Normal Population: Effect of Age and Sex in Addition to Body Size
1994
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Cooperation of synthetic insulin-like growth factor I/somatomedin C and 1,25-dihydroxyvitamin D3 on regulation of function in clonal osteoblastic cells
1989
Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive
2002
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate‐to‐severe reductions in renal function
2005
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
Long-Term Dual Blockade With Candesartan and Lisinopril in Hypertensive Patients With Diabetes
2005
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Dual Blockade of the Renin-Angiotensin System for Cardiorenal Protection: An Update
2009
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
2008
Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor
2003
Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
2008
Vitamin D3Improves Impaired Glucose Tolerance and Insulin Secretion in the Vitamin D-Deficient Ratin Vivo
1986
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
2004
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
1999 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Mechanisms of Diabetic Complications
2013 Standout
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
2009
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation
2002
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens
2011
Salt and water retention and calcium blockade in uremia.
1990
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
2002
Utility of Influenza Vaccination for Oncology Patients
2010
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of S Oren being referenced
Resource savings from non-pharmacological control of hypertension.
1990
Sex differences in cardiac adaptation to essential hypertension
1989
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response
2007
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study
2000
Does 1,25-Dihydroxyvitamin D Participate in the Regulation of Hormone Release from Endocrine Glands?*
1985
Mitral valve prolapse. Quantitative analysis and long-term follow-up.
1985
Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension.
1988